Proceedings: Primary liver cancer. A review of the clinical features, blood groups, serum enzymes, therapy, and survival of 65 cases.
D000017:ABO Blood-Group System; D002759:Adenoma, Bile Duct / Q000097:blood / Q000175:diagnosis / Q000188:drug therapy / Q000201:enzymology / Q000401:mortality; D000293:Adolescent; D000328:Adult; D000368:Aged; D000410:Alanine Transaminase / Q000097:blood*; D000469:Alkaline Phosphatase / Q000097:blood*; D001219:Aspartate Aminotransferases / Q000097:blood*; D006528:Carcinoma, Hepatocellular / Q000097:blood / Q000175:diagnosis / Q000188:drug therapy / Q000201:enzymology / Q000401:mortality; D005260:Female; D005472:Fluorouracil / Q000627:therapeutic use*; D006394:Hemangiosarcoma / Q000097:blood / Q000175:diagnosis / Q000188:drug therapy / Q000201:enzymology / Q000401:mortality; D006801:Humans; D007770:L-Lactate Dehydrogenase / Q000097:blood*; D008113:Liver Neoplasms / Q000097:blood / Q000175:diagnosis / Q000188:drug therapy / Q000201:enzymology / Q000401:mortality; D008297:Male; D008875:Middle Aged
D000017:ABO Blood-Group System; D007770:L-Lactate Dehydrogenase; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase; D000469:Alkaline Phosphatase; D005472:Fluorouracil